Global Cellular and Gene Therapy Product Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031
According to our (Global Info Research) latest study, the global Cellular and Gene Therapy Product market size was valued at US$ million in 2024 and is forecast to a readjusted size of USD million by 2031 with a CAGR of %during review period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report is a detailed and comprehensive analysis for global Cellular and Gene Therapy Product market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Cellular and Gene Therapy Product market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Cellular and Gene Therapy Product market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Cellular and Gene Therapy Product market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Cellular and Gene Therapy Product market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Cellular and Gene Therapy Product
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Cellular and Gene Therapy Product market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Bristol-Myers Squibb, New York Blood Center, Johnson & Johnson, Cleveland Cord Blood Center, Organogenesis, Duke University School of Medicine, Colorado Cord Blood Banking, MD Anderson Cancer Center, LifeSouth Community Blood Centers, Bloodworks Northwest, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Cellular and Gene Therapy Product market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Cellular Immunotherapies
- Cancer Vaccines
- Autologous and Allogeneic Cells
Market segment by Application
- Blood Cancer
- Prostate Cancer
- Skin Cancer
- Other
Major players covered
- Bristol-Myers Squibb
- New York Blood Center
- Johnson & Johnson
- Cleveland Cord Blood Center
- Organogenesis
- Duke University School of Medicine
- Colorado Cord Blood Banking
- MD Anderson Cancer Center
- LifeSouth Community Blood Centers
- Bloodworks Northwest
- Amgen
- Novartis Pharmaceuticals
- Castle Creek Biosciences
- Spark Therapeutics
- Vericel
- Dendreon Pharmaceuticals
- Enzyvant Therapeutics GmbH
- Mallinckrodt
- Gilead Sciences
- bluebird bio
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Cellular and Gene Therapy Product product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Cellular and Gene Therapy Product, with price, sales quantity, revenue, and global market share of Cellular and Gene Therapy Product from 2020 to 2025.
Chapter 3, the Cellular and Gene Therapy Product competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Cellular and Gene Therapy Product breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Cellular and Gene Therapy Product market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Cellular and Gene Therapy Product.
Chapter 14 and 15, to describe Cellular and Gene Therapy Product sales channel, distributors, customers, research findings and conclusion.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report is a detailed and comprehensive analysis for global Cellular and Gene Therapy Product market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Cellular and Gene Therapy Product market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Cellular and Gene Therapy Product market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Cellular and Gene Therapy Product market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Cellular and Gene Therapy Product market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Cellular and Gene Therapy Product
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Cellular and Gene Therapy Product market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Bristol-Myers Squibb, New York Blood Center, Johnson & Johnson, Cleveland Cord Blood Center, Organogenesis, Duke University School of Medicine, Colorado Cord Blood Banking, MD Anderson Cancer Center, LifeSouth Community Blood Centers, Bloodworks Northwest, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Cellular and Gene Therapy Product market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Cellular Immunotherapies
- Cancer Vaccines
- Autologous and Allogeneic Cells
Market segment by Application
- Blood Cancer
- Prostate Cancer
- Skin Cancer
- Other
Major players covered
- Bristol-Myers Squibb
- New York Blood Center
- Johnson & Johnson
- Cleveland Cord Blood Center
- Organogenesis
- Duke University School of Medicine
- Colorado Cord Blood Banking
- MD Anderson Cancer Center
- LifeSouth Community Blood Centers
- Bloodworks Northwest
- Amgen
- Novartis Pharmaceuticals
- Castle Creek Biosciences
- Spark Therapeutics
- Vericel
- Dendreon Pharmaceuticals
- Enzyvant Therapeutics GmbH
- Mallinckrodt
- Gilead Sciences
- bluebird bio
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Cellular and Gene Therapy Product product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Cellular and Gene Therapy Product, with price, sales quantity, revenue, and global market share of Cellular and Gene Therapy Product from 2020 to 2025.
Chapter 3, the Cellular and Gene Therapy Product competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Cellular and Gene Therapy Product breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Cellular and Gene Therapy Product market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Cellular and Gene Therapy Product.
Chapter 14 and 15, to describe Cellular and Gene Therapy Product sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Cellular and Gene Therapy Product Consumption Value by Type: 2020 Versus 2024 Versus 2031
1.3.2 Cellular Immunotherapies
1.3.3 Cancer Vaccines
1.3.4 Autologous and Allogeneic Cells
1.4 Market Analysis by Application
1.4.1 Overview: Global Cellular and Gene Therapy Product Consumption Value by Application: 2020 Versus 2024 Versus 2031
1.4.2 Blood Cancer
1.4.3 Prostate Cancer
1.4.4 Skin Cancer
1.4.5 Other
1.5 Global Cellular and Gene Therapy Product Market Size & Forecast
1.5.1 Global Cellular and Gene Therapy Product Consumption Value (2020 & 2024 & 2031)
1.5.2 Global Cellular and Gene Therapy Product Sales Quantity (2020-2031)
1.5.3 Global Cellular and Gene Therapy Product Average Price (2020-2031)
2 MANUFACTURERS PROFILES
2.1 Bristol-Myers Squibb
2.1.1 Bristol-Myers Squibb Details
2.1.2 Bristol-Myers Squibb Major Business
2.1.3 Bristol-Myers Squibb Cellular and Gene Therapy Product Product and Services
2.1.4 Bristol-Myers Squibb Cellular and Gene Therapy Product Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.1.5 Bristol-Myers Squibb Recent Developments/Updates
2.2 New York Blood Center
2.2.1 New York Blood Center Details
2.2.2 New York Blood Center Major Business
2.2.3 New York Blood Center Cellular and Gene Therapy Product Product and Services
2.2.4 New York Blood Center Cellular and Gene Therapy Product Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.2.5 New York Blood Center Recent Developments/Updates
2.3 Johnson & Johnson
2.3.1 Johnson & Johnson Details
2.3.2 Johnson & Johnson Major Business
2.3.3 Johnson & Johnson Cellular and Gene Therapy Product Product and Services
2.3.4 Johnson & Johnson Cellular and Gene Therapy Product Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.3.5 Johnson & Johnson Recent Developments/Updates
2.4 Cleveland Cord Blood Center
2.4.1 Cleveland Cord Blood Center Details
2.4.2 Cleveland Cord Blood Center Major Business
2.4.3 Cleveland Cord Blood Center Cellular and Gene Therapy Product Product and Services
2.4.4 Cleveland Cord Blood Center Cellular and Gene Therapy Product Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.4.5 Cleveland Cord Blood Center Recent Developments/Updates
2.5 Organogenesis
2.5.1 Organogenesis Details
2.5.2 Organogenesis Major Business
2.5.3 Organogenesis Cellular and Gene Therapy Product Product and Services
2.5.4 Organogenesis Cellular and Gene Therapy Product Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.5.5 Organogenesis Recent Developments/Updates
2.6 Duke University School of Medicine
2.6.1 Duke University School of Medicine Details
2.6.2 Duke University School of Medicine Major Business
2.6.3 Duke University School of Medicine Cellular and Gene Therapy Product Product and Services
2.6.4 Duke University School of Medicine Cellular and Gene Therapy Product Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.6.5 Duke University School of Medicine Recent Developments/Updates
2.7 Colorado Cord Blood Banking
2.7.1 Colorado Cord Blood Banking Details
2.7.2 Colorado Cord Blood Banking Major Business
2.7.3 Colorado Cord Blood Banking Cellular and Gene Therapy Product Product and Services
2.7.4 Colorado Cord Blood Banking Cellular and Gene Therapy Product Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.7.5 Colorado Cord Blood Banking Recent Developments/Updates
2.8 MD Anderson Cancer Center
2.8.1 MD Anderson Cancer Center Details
2.8.2 MD Anderson Cancer Center Major Business
2.8.3 MD Anderson Cancer Center Cellular and Gene Therapy Product Product and Services
2.8.4 MD Anderson Cancer Center Cellular and Gene Therapy Product Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.8.5 MD Anderson Cancer Center Recent Developments/Updates
2.9 LifeSouth Community Blood Centers
2.9.1 LifeSouth Community Blood Centers Details
2.9.2 LifeSouth Community Blood Centers Major Business
2.9.3 LifeSouth Community Blood Centers Cellular and Gene Therapy Product Product and Services
2.9.4 LifeSouth Community Blood Centers Cellular and Gene Therapy Product Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.9.5 LifeSouth Community Blood Centers Recent Developments/Updates
2.10 Bloodworks Northwest
2.10.1 Bloodworks Northwest Details
2.10.2 Bloodworks Northwest Major Business
2.10.3 Bloodworks Northwest Cellular and Gene Therapy Product Product and Services
2.10.4 Bloodworks Northwest Cellular and Gene Therapy Product Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.10.5 Bloodworks Northwest Recent Developments/Updates
2.11 Amgen
2.11.1 Amgen Details
2.11.2 Amgen Major Business
2.11.3 Amgen Cellular and Gene Therapy Product Product and Services
2.11.4 Amgen Cellular and Gene Therapy Product Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.11.5 Amgen Recent Developments/Updates
2.12 Novartis Pharmaceuticals
2.12.1 Novartis Pharmaceuticals Details
2.12.2 Novartis Pharmaceuticals Major Business
2.12.3 Novartis Pharmaceuticals Cellular and Gene Therapy Product Product and Services
2.12.4 Novartis Pharmaceuticals Cellular and Gene Therapy Product Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.12.5 Novartis Pharmaceuticals Recent Developments/Updates
2.13 Castle Creek Biosciences
2.13.1 Castle Creek Biosciences Details
2.13.2 Castle Creek Biosciences Major Business
2.13.3 Castle Creek Biosciences Cellular and Gene Therapy Product Product and Services
2.13.4 Castle Creek Biosciences Cellular and Gene Therapy Product Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.13.5 Castle Creek Biosciences Recent Developments/Updates
2.14 Spark Therapeutics
2.14.1 Spark Therapeutics Details
2.14.2 Spark Therapeutics Major Business
2.14.3 Spark Therapeutics Cellular and Gene Therapy Product Product and Services
2.14.4 Spark Therapeutics Cellular and Gene Therapy Product Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.14.5 Spark Therapeutics Recent Developments/Updates
2.15 Vericel
2.15.1 Vericel Details
2.15.2 Vericel Major Business
2.15.3 Vericel Cellular and Gene Therapy Product Product and Services
2.15.4 Vericel Cellular and Gene Therapy Product Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.15.5 Vericel Recent Developments/Updates
2.16 Dendreon Pharmaceuticals
2.16.1 Dendreon Pharmaceuticals Details
2.16.2 Dendreon Pharmaceuticals Major Business
2.16.3 Dendreon Pharmaceuticals Cellular and Gene Therapy Product Product and Services
2.16.4 Dendreon Pharmaceuticals Cellular and Gene Therapy Product Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.16.5 Dendreon Pharmaceuticals Recent Developments/Updates
2.17 Enzyvant Therapeutics GmbH
2.17.1 Enzyvant Therapeutics GmbH Details
2.17.2 Enzyvant Therapeutics GmbH Major Business
2.17.3 Enzyvant Therapeutics GmbH Cellular and Gene Therapy Product Product and Services
2.17.4 Enzyvant Therapeutics GmbH Cellular and Gene Therapy Product Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.17.5 Enzyvant Therapeutics GmbH Recent Developments/Updates
2.18 Mallinckrodt
2.18.1 Mallinckrodt Details
2.18.2 Mallinckrodt Major Business
2.18.3 Mallinckrodt Cellular and Gene Therapy Product Product and Services
2.18.4 Mallinckrodt Cellular and Gene Therapy Product Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.18.5 Mallinckrodt Recent Developments/Updates
2.19 Gilead Sciences
2.19.1 Gilead Sciences Details
2.19.2 Gilead Sciences Major Business
2.19.3 Gilead Sciences Cellular and Gene Therapy Product Product and Services
2.19.4 Gilead Sciences Cellular and Gene Therapy Product Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.19.5 Gilead Sciences Recent Developments/Updates
2.20 bluebird bio
2.20.1 bluebird bio Details
2.20.2 bluebird bio Major Business
2.20.3 bluebird bio Cellular and Gene Therapy Product Product and Services
2.20.4 bluebird bio Cellular and Gene Therapy Product Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.20.5 bluebird bio Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: CELLULAR AND GENE THERAPY PRODUCT BY MANUFACTURER
3.1 Global Cellular and Gene Therapy Product Sales Quantity by Manufacturer (2020-2025)
3.2 Global Cellular and Gene Therapy Product Revenue by Manufacturer (2020-2025)
3.3 Global Cellular and Gene Therapy Product Average Price by Manufacturer (2020-2025)
3.4 Market Share Analysis (2024)
3.4.1 Producer Shipments of Cellular and Gene Therapy Product by Manufacturer Revenue ($MM) and Market Share (%): 2024
3.4.2 Top 3 Cellular and Gene Therapy Product Manufacturer Market Share in 2024
3.4.3 Top 6 Cellular and Gene Therapy Product Manufacturer Market Share in 2024
3.5 Cellular and Gene Therapy Product Market: Overall Company Footprint Analysis
3.5.1 Cellular and Gene Therapy Product Market: Region Footprint
3.5.2 Cellular and Gene Therapy Product Market: Company Product Type Footprint
3.5.3 Cellular and Gene Therapy Product Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Cellular and Gene Therapy Product Market Size by Region
4.1.1 Global Cellular and Gene Therapy Product Sales Quantity by Region (2020-2031)
4.1.2 Global Cellular and Gene Therapy Product Consumption Value by Region (2020-2031)
4.1.3 Global Cellular and Gene Therapy Product Average Price by Region (2020-2031)
4.2 North America Cellular and Gene Therapy Product Consumption Value (2020-2031)
4.3 Europe Cellular and Gene Therapy Product Consumption Value (2020-2031)
4.4 Asia-Pacific Cellular and Gene Therapy Product Consumption Value (2020-2031)
4.5 South America Cellular and Gene Therapy Product Consumption Value (2020-2031)
4.6 Middle East & Africa Cellular and Gene Therapy Product Consumption Value (2020-2031)
5 MARKET SEGMENT BY TYPE
5.1 Global Cellular and Gene Therapy Product Sales Quantity by Type (2020-2031)
5.2 Global Cellular and Gene Therapy Product Consumption Value by Type (2020-2031)
5.3 Global Cellular and Gene Therapy Product Average Price by Type (2020-2031)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Cellular and Gene Therapy Product Sales Quantity by Application (2020-2031)
6.2 Global Cellular and Gene Therapy Product Consumption Value by Application (2020-2031)
6.3 Global Cellular and Gene Therapy Product Average Price by Application (2020-2031)
7 NORTH AMERICA
7.1 North America Cellular and Gene Therapy Product Sales Quantity by Type (2020-2031)
7.2 North America Cellular and Gene Therapy Product Sales Quantity by Application (2020-2031)
7.3 North America Cellular and Gene Therapy Product Market Size by Country
7.3.1 North America Cellular and Gene Therapy Product Sales Quantity by Country (2020-2031)
7.3.2 North America Cellular and Gene Therapy Product Consumption Value by Country (2020-2031)
7.3.3 United States Market Size and Forecast (2020-2031)
7.3.4 Canada Market Size and Forecast (2020-2031)
7.3.5 Mexico Market Size and Forecast (2020-2031)
8 EUROPE
8.1 Europe Cellular and Gene Therapy Product Sales Quantity by Type (2020-2031)
8.2 Europe Cellular and Gene Therapy Product Sales Quantity by Application (2020-2031)
8.3 Europe Cellular and Gene Therapy Product Market Size by Country
8.3.1 Europe Cellular and Gene Therapy Product Sales Quantity by Country (2020-2031)
8.3.2 Europe Cellular and Gene Therapy Product Consumption Value by Country (2020-2031)
8.3.3 Germany Market Size and Forecast (2020-2031)
8.3.4 France Market Size and Forecast (2020-2031)
8.3.5 United Kingdom Market Size and Forecast (2020-2031)
8.3.6 Russia Market Size and Forecast (2020-2031)
8.3.7 Italy Market Size and Forecast (2020-2031)
9 ASIA-PACIFIC
9.1 Asia-Pacific Cellular and Gene Therapy Product Sales Quantity by Type (2020-2031)
9.2 Asia-Pacific Cellular and Gene Therapy Product Sales Quantity by Application (2020-2031)
9.3 Asia-Pacific Cellular and Gene Therapy Product Market Size by Region
9.3.1 Asia-Pacific Cellular and Gene Therapy Product Sales Quantity by Region (2020-2031)
9.3.2 Asia-Pacific Cellular and Gene Therapy Product Consumption Value by Region (2020-2031)
9.3.3 China Market Size and Forecast (2020-2031)
9.3.4 Japan Market Size and Forecast (2020-2031)
9.3.5 South Korea Market Size and Forecast (2020-2031)
9.3.6 India Market Size and Forecast (2020-2031)
9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
9.3.8 Australia Market Size and Forecast (2020-2031)
10 SOUTH AMERICA
10.1 South America Cellular and Gene Therapy Product Sales Quantity by Type (2020-2031)
10.2 South America Cellular and Gene Therapy Product Sales Quantity by Application (2020-2031)
10.3 South America Cellular and Gene Therapy Product Market Size by Country
10.3.1 South America Cellular and Gene Therapy Product Sales Quantity by Country (2020-2031)
10.3.2 South America Cellular and Gene Therapy Product Consumption Value by Country (2020-2031)
10.3.3 Brazil Market Size and Forecast (2020-2031)
10.3.4 Argentina Market Size and Forecast (2020-2031)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Cellular and Gene Therapy Product Sales Quantity by Type (2020-2031)
11.2 Middle East & Africa Cellular and Gene Therapy Product Sales Quantity by Application (2020-2031)
11.3 Middle East & Africa Cellular and Gene Therapy Product Market Size by Country
11.3.1 Middle East & Africa Cellular and Gene Therapy Product Sales Quantity by Country (2020-2031)
11.3.2 Middle East & Africa Cellular and Gene Therapy Product Consumption Value by Country (2020-2031)
11.3.3 Turkey Market Size and Forecast (2020-2031)
11.3.4 Egypt Market Size and Forecast (2020-2031)
11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
11.3.6 South Africa Market Size and Forecast (2020-2031)
12 MARKET DYNAMICS
12.1 Cellular and Gene Therapy Product Market Drivers
12.2 Cellular and Gene Therapy Product Market Restraints
12.3 Cellular and Gene Therapy Product Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Cellular and Gene Therapy Product and Key Manufacturers
13.2 Manufacturing Costs Percentage of Cellular and Gene Therapy Product
13.3 Cellular and Gene Therapy Product Production Process
13.4 Industry Value Chain Analysis
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Cellular and Gene Therapy Product Typical Distributors
14.3 Cellular and Gene Therapy Product Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Cellular and Gene Therapy Product Consumption Value by Type: 2020 Versus 2024 Versus 2031
1.3.2 Cellular Immunotherapies
1.3.3 Cancer Vaccines
1.3.4 Autologous and Allogeneic Cells
1.4 Market Analysis by Application
1.4.1 Overview: Global Cellular and Gene Therapy Product Consumption Value by Application: 2020 Versus 2024 Versus 2031
1.4.2 Blood Cancer
1.4.3 Prostate Cancer
1.4.4 Skin Cancer
1.4.5 Other
1.5 Global Cellular and Gene Therapy Product Market Size & Forecast
1.5.1 Global Cellular and Gene Therapy Product Consumption Value (2020 & 2024 & 2031)
1.5.2 Global Cellular and Gene Therapy Product Sales Quantity (2020-2031)
1.5.3 Global Cellular and Gene Therapy Product Average Price (2020-2031)
2 MANUFACTURERS PROFILES
2.1 Bristol-Myers Squibb
2.1.1 Bristol-Myers Squibb Details
2.1.2 Bristol-Myers Squibb Major Business
2.1.3 Bristol-Myers Squibb Cellular and Gene Therapy Product Product and Services
2.1.4 Bristol-Myers Squibb Cellular and Gene Therapy Product Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.1.5 Bristol-Myers Squibb Recent Developments/Updates
2.2 New York Blood Center
2.2.1 New York Blood Center Details
2.2.2 New York Blood Center Major Business
2.2.3 New York Blood Center Cellular and Gene Therapy Product Product and Services
2.2.4 New York Blood Center Cellular and Gene Therapy Product Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.2.5 New York Blood Center Recent Developments/Updates
2.3 Johnson & Johnson
2.3.1 Johnson & Johnson Details
2.3.2 Johnson & Johnson Major Business
2.3.3 Johnson & Johnson Cellular and Gene Therapy Product Product and Services
2.3.4 Johnson & Johnson Cellular and Gene Therapy Product Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.3.5 Johnson & Johnson Recent Developments/Updates
2.4 Cleveland Cord Blood Center
2.4.1 Cleveland Cord Blood Center Details
2.4.2 Cleveland Cord Blood Center Major Business
2.4.3 Cleveland Cord Blood Center Cellular and Gene Therapy Product Product and Services
2.4.4 Cleveland Cord Blood Center Cellular and Gene Therapy Product Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.4.5 Cleveland Cord Blood Center Recent Developments/Updates
2.5 Organogenesis
2.5.1 Organogenesis Details
2.5.2 Organogenesis Major Business
2.5.3 Organogenesis Cellular and Gene Therapy Product Product and Services
2.5.4 Organogenesis Cellular and Gene Therapy Product Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.5.5 Organogenesis Recent Developments/Updates
2.6 Duke University School of Medicine
2.6.1 Duke University School of Medicine Details
2.6.2 Duke University School of Medicine Major Business
2.6.3 Duke University School of Medicine Cellular and Gene Therapy Product Product and Services
2.6.4 Duke University School of Medicine Cellular and Gene Therapy Product Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.6.5 Duke University School of Medicine Recent Developments/Updates
2.7 Colorado Cord Blood Banking
2.7.1 Colorado Cord Blood Banking Details
2.7.2 Colorado Cord Blood Banking Major Business
2.7.3 Colorado Cord Blood Banking Cellular and Gene Therapy Product Product and Services
2.7.4 Colorado Cord Blood Banking Cellular and Gene Therapy Product Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.7.5 Colorado Cord Blood Banking Recent Developments/Updates
2.8 MD Anderson Cancer Center
2.8.1 MD Anderson Cancer Center Details
2.8.2 MD Anderson Cancer Center Major Business
2.8.3 MD Anderson Cancer Center Cellular and Gene Therapy Product Product and Services
2.8.4 MD Anderson Cancer Center Cellular and Gene Therapy Product Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.8.5 MD Anderson Cancer Center Recent Developments/Updates
2.9 LifeSouth Community Blood Centers
2.9.1 LifeSouth Community Blood Centers Details
2.9.2 LifeSouth Community Blood Centers Major Business
2.9.3 LifeSouth Community Blood Centers Cellular and Gene Therapy Product Product and Services
2.9.4 LifeSouth Community Blood Centers Cellular and Gene Therapy Product Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.9.5 LifeSouth Community Blood Centers Recent Developments/Updates
2.10 Bloodworks Northwest
2.10.1 Bloodworks Northwest Details
2.10.2 Bloodworks Northwest Major Business
2.10.3 Bloodworks Northwest Cellular and Gene Therapy Product Product and Services
2.10.4 Bloodworks Northwest Cellular and Gene Therapy Product Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.10.5 Bloodworks Northwest Recent Developments/Updates
2.11 Amgen
2.11.1 Amgen Details
2.11.2 Amgen Major Business
2.11.3 Amgen Cellular and Gene Therapy Product Product and Services
2.11.4 Amgen Cellular and Gene Therapy Product Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.11.5 Amgen Recent Developments/Updates
2.12 Novartis Pharmaceuticals
2.12.1 Novartis Pharmaceuticals Details
2.12.2 Novartis Pharmaceuticals Major Business
2.12.3 Novartis Pharmaceuticals Cellular and Gene Therapy Product Product and Services
2.12.4 Novartis Pharmaceuticals Cellular and Gene Therapy Product Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.12.5 Novartis Pharmaceuticals Recent Developments/Updates
2.13 Castle Creek Biosciences
2.13.1 Castle Creek Biosciences Details
2.13.2 Castle Creek Biosciences Major Business
2.13.3 Castle Creek Biosciences Cellular and Gene Therapy Product Product and Services
2.13.4 Castle Creek Biosciences Cellular and Gene Therapy Product Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.13.5 Castle Creek Biosciences Recent Developments/Updates
2.14 Spark Therapeutics
2.14.1 Spark Therapeutics Details
2.14.2 Spark Therapeutics Major Business
2.14.3 Spark Therapeutics Cellular and Gene Therapy Product Product and Services
2.14.4 Spark Therapeutics Cellular and Gene Therapy Product Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.14.5 Spark Therapeutics Recent Developments/Updates
2.15 Vericel
2.15.1 Vericel Details
2.15.2 Vericel Major Business
2.15.3 Vericel Cellular and Gene Therapy Product Product and Services
2.15.4 Vericel Cellular and Gene Therapy Product Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.15.5 Vericel Recent Developments/Updates
2.16 Dendreon Pharmaceuticals
2.16.1 Dendreon Pharmaceuticals Details
2.16.2 Dendreon Pharmaceuticals Major Business
2.16.3 Dendreon Pharmaceuticals Cellular and Gene Therapy Product Product and Services
2.16.4 Dendreon Pharmaceuticals Cellular and Gene Therapy Product Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.16.5 Dendreon Pharmaceuticals Recent Developments/Updates
2.17 Enzyvant Therapeutics GmbH
2.17.1 Enzyvant Therapeutics GmbH Details
2.17.2 Enzyvant Therapeutics GmbH Major Business
2.17.3 Enzyvant Therapeutics GmbH Cellular and Gene Therapy Product Product and Services
2.17.4 Enzyvant Therapeutics GmbH Cellular and Gene Therapy Product Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.17.5 Enzyvant Therapeutics GmbH Recent Developments/Updates
2.18 Mallinckrodt
2.18.1 Mallinckrodt Details
2.18.2 Mallinckrodt Major Business
2.18.3 Mallinckrodt Cellular and Gene Therapy Product Product and Services
2.18.4 Mallinckrodt Cellular and Gene Therapy Product Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.18.5 Mallinckrodt Recent Developments/Updates
2.19 Gilead Sciences
2.19.1 Gilead Sciences Details
2.19.2 Gilead Sciences Major Business
2.19.3 Gilead Sciences Cellular and Gene Therapy Product Product and Services
2.19.4 Gilead Sciences Cellular and Gene Therapy Product Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.19.5 Gilead Sciences Recent Developments/Updates
2.20 bluebird bio
2.20.1 bluebird bio Details
2.20.2 bluebird bio Major Business
2.20.3 bluebird bio Cellular and Gene Therapy Product Product and Services
2.20.4 bluebird bio Cellular and Gene Therapy Product Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.20.5 bluebird bio Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: CELLULAR AND GENE THERAPY PRODUCT BY MANUFACTURER
3.1 Global Cellular and Gene Therapy Product Sales Quantity by Manufacturer (2020-2025)
3.2 Global Cellular and Gene Therapy Product Revenue by Manufacturer (2020-2025)
3.3 Global Cellular and Gene Therapy Product Average Price by Manufacturer (2020-2025)
3.4 Market Share Analysis (2024)
3.4.1 Producer Shipments of Cellular and Gene Therapy Product by Manufacturer Revenue ($MM) and Market Share (%): 2024
3.4.2 Top 3 Cellular and Gene Therapy Product Manufacturer Market Share in 2024
3.4.3 Top 6 Cellular and Gene Therapy Product Manufacturer Market Share in 2024
3.5 Cellular and Gene Therapy Product Market: Overall Company Footprint Analysis
3.5.1 Cellular and Gene Therapy Product Market: Region Footprint
3.5.2 Cellular and Gene Therapy Product Market: Company Product Type Footprint
3.5.3 Cellular and Gene Therapy Product Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Cellular and Gene Therapy Product Market Size by Region
4.1.1 Global Cellular and Gene Therapy Product Sales Quantity by Region (2020-2031)
4.1.2 Global Cellular and Gene Therapy Product Consumption Value by Region (2020-2031)
4.1.3 Global Cellular and Gene Therapy Product Average Price by Region (2020-2031)
4.2 North America Cellular and Gene Therapy Product Consumption Value (2020-2031)
4.3 Europe Cellular and Gene Therapy Product Consumption Value (2020-2031)
4.4 Asia-Pacific Cellular and Gene Therapy Product Consumption Value (2020-2031)
4.5 South America Cellular and Gene Therapy Product Consumption Value (2020-2031)
4.6 Middle East & Africa Cellular and Gene Therapy Product Consumption Value (2020-2031)
5 MARKET SEGMENT BY TYPE
5.1 Global Cellular and Gene Therapy Product Sales Quantity by Type (2020-2031)
5.2 Global Cellular and Gene Therapy Product Consumption Value by Type (2020-2031)
5.3 Global Cellular and Gene Therapy Product Average Price by Type (2020-2031)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Cellular and Gene Therapy Product Sales Quantity by Application (2020-2031)
6.2 Global Cellular and Gene Therapy Product Consumption Value by Application (2020-2031)
6.3 Global Cellular and Gene Therapy Product Average Price by Application (2020-2031)
7 NORTH AMERICA
7.1 North America Cellular and Gene Therapy Product Sales Quantity by Type (2020-2031)
7.2 North America Cellular and Gene Therapy Product Sales Quantity by Application (2020-2031)
7.3 North America Cellular and Gene Therapy Product Market Size by Country
7.3.1 North America Cellular and Gene Therapy Product Sales Quantity by Country (2020-2031)
7.3.2 North America Cellular and Gene Therapy Product Consumption Value by Country (2020-2031)
7.3.3 United States Market Size and Forecast (2020-2031)
7.3.4 Canada Market Size and Forecast (2020-2031)
7.3.5 Mexico Market Size and Forecast (2020-2031)
8 EUROPE
8.1 Europe Cellular and Gene Therapy Product Sales Quantity by Type (2020-2031)
8.2 Europe Cellular and Gene Therapy Product Sales Quantity by Application (2020-2031)
8.3 Europe Cellular and Gene Therapy Product Market Size by Country
8.3.1 Europe Cellular and Gene Therapy Product Sales Quantity by Country (2020-2031)
8.3.2 Europe Cellular and Gene Therapy Product Consumption Value by Country (2020-2031)
8.3.3 Germany Market Size and Forecast (2020-2031)
8.3.4 France Market Size and Forecast (2020-2031)
8.3.5 United Kingdom Market Size and Forecast (2020-2031)
8.3.6 Russia Market Size and Forecast (2020-2031)
8.3.7 Italy Market Size and Forecast (2020-2031)
9 ASIA-PACIFIC
9.1 Asia-Pacific Cellular and Gene Therapy Product Sales Quantity by Type (2020-2031)
9.2 Asia-Pacific Cellular and Gene Therapy Product Sales Quantity by Application (2020-2031)
9.3 Asia-Pacific Cellular and Gene Therapy Product Market Size by Region
9.3.1 Asia-Pacific Cellular and Gene Therapy Product Sales Quantity by Region (2020-2031)
9.3.2 Asia-Pacific Cellular and Gene Therapy Product Consumption Value by Region (2020-2031)
9.3.3 China Market Size and Forecast (2020-2031)
9.3.4 Japan Market Size and Forecast (2020-2031)
9.3.5 South Korea Market Size and Forecast (2020-2031)
9.3.6 India Market Size and Forecast (2020-2031)
9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
9.3.8 Australia Market Size and Forecast (2020-2031)
10 SOUTH AMERICA
10.1 South America Cellular and Gene Therapy Product Sales Quantity by Type (2020-2031)
10.2 South America Cellular and Gene Therapy Product Sales Quantity by Application (2020-2031)
10.3 South America Cellular and Gene Therapy Product Market Size by Country
10.3.1 South America Cellular and Gene Therapy Product Sales Quantity by Country (2020-2031)
10.3.2 South America Cellular and Gene Therapy Product Consumption Value by Country (2020-2031)
10.3.3 Brazil Market Size and Forecast (2020-2031)
10.3.4 Argentina Market Size and Forecast (2020-2031)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Cellular and Gene Therapy Product Sales Quantity by Type (2020-2031)
11.2 Middle East & Africa Cellular and Gene Therapy Product Sales Quantity by Application (2020-2031)
11.3 Middle East & Africa Cellular and Gene Therapy Product Market Size by Country
11.3.1 Middle East & Africa Cellular and Gene Therapy Product Sales Quantity by Country (2020-2031)
11.3.2 Middle East & Africa Cellular and Gene Therapy Product Consumption Value by Country (2020-2031)
11.3.3 Turkey Market Size and Forecast (2020-2031)
11.3.4 Egypt Market Size and Forecast (2020-2031)
11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
11.3.6 South Africa Market Size and Forecast (2020-2031)
12 MARKET DYNAMICS
12.1 Cellular and Gene Therapy Product Market Drivers
12.2 Cellular and Gene Therapy Product Market Restraints
12.3 Cellular and Gene Therapy Product Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Cellular and Gene Therapy Product and Key Manufacturers
13.2 Manufacturing Costs Percentage of Cellular and Gene Therapy Product
13.3 Cellular and Gene Therapy Product Production Process
13.4 Industry Value Chain Analysis
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Cellular and Gene Therapy Product Typical Distributors
14.3 Cellular and Gene Therapy Product Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global Cellular and Gene Therapy Product Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
Table 2. Global Cellular and Gene Therapy Product Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Table 3. Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table 4. Bristol-Myers Squibb Major Business
Table 5. Bristol-Myers Squibb Cellular and Gene Therapy Product Product and Services
Table 6. Bristol-Myers Squibb Cellular and Gene Therapy Product Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 7. Bristol-Myers Squibb Recent Developments/Updates
Table 8. New York Blood Center Basic Information, Manufacturing Base and Competitors
Table 9. New York Blood Center Major Business
Table 10. New York Blood Center Cellular and Gene Therapy Product Product and Services
Table 11. New York Blood Center Cellular and Gene Therapy Product Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 12. New York Blood Center Recent Developments/Updates
Table 13. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 14. Johnson & Johnson Major Business
Table 15. Johnson & Johnson Cellular and Gene Therapy Product Product and Services
Table 16. Johnson & Johnson Cellular and Gene Therapy Product Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 17. Johnson & Johnson Recent Developments/Updates
Table 18. Cleveland Cord Blood Center Basic Information, Manufacturing Base and Competitors
Table 19. Cleveland Cord Blood Center Major Business
Table 20. Cleveland Cord Blood Center Cellular and Gene Therapy Product Product and Services
Table 21. Cleveland Cord Blood Center Cellular and Gene Therapy Product Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 22. Cleveland Cord Blood Center Recent Developments/Updates
Table 23. Organogenesis Basic Information, Manufacturing Base and Competitors
Table 24. Organogenesis Major Business
Table 25. Organogenesis Cellular and Gene Therapy Product Product and Services
Table 26. Organogenesis Cellular and Gene Therapy Product Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 27. Organogenesis Recent Developments/Updates
Table 28. Duke University School of Medicine Basic Information, Manufacturing Base and Competitors
Table 29. Duke University School of Medicine Major Business
Table 30. Duke University School of Medicine Cellular and Gene Therapy Product Product and Services
Table 31. Duke University School of Medicine Cellular and Gene Therapy Product Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 32. Duke University School of Medicine Recent Developments/Updates
Table 33. Colorado Cord Blood Banking Basic Information, Manufacturing Base and Competitors
Table 34. Colorado Cord Blood Banking Major Business
Table 35. Colorado Cord Blood Banking Cellular and Gene Therapy Product Product and Services
Table 36. Colorado Cord Blood Banking Cellular and Gene Therapy Product Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 37. Colorado Cord Blood Banking Recent Developments/Updates
Table 38. MD Anderson Cancer Center Basic Information, Manufacturing Base and Competitors
Table 39. MD Anderson Cancer Center Major Business
Table 40. MD Anderson Cancer Center Cellular and Gene Therapy Product Product and Services
Table 41. MD Anderson Cancer Center Cellular and Gene Therapy Product Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 42. MD Anderson Cancer Center Recent Developments/Updates
Table 43. LifeSouth Community Blood Centers Basic Information, Manufacturing Base and Competitors
Table 44. LifeSouth Community Blood Centers Major Business
Table 45. LifeSouth Community Blood Centers Cellular and Gene Therapy Product Product and Services
Table 46. LifeSouth Community Blood Centers Cellular and Gene Therapy Product Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 47. LifeSouth Community Blood Centers Recent Developments/Updates
Table 48. Bloodworks Northwest Basic Information, Manufacturing Base and Competitors
Table 49. Bloodworks Northwest Major Business
Table 50. Bloodworks Northwest Cellular and Gene Therapy Product Product and Services
Table 51. Bloodworks Northwest Cellular and Gene Therapy Product Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 52. Bloodworks Northwest Recent Developments/Updates
Table 53. Amgen Basic Information, Manufacturing Base and Competitors
Table 54. Amgen Major Business
Table 55. Amgen Cellular and Gene Therapy Product Product and Services
Table 56. Amgen Cellular and Gene Therapy Product Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 57. Amgen Recent Developments/Updates
Table 58. Novartis Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 59. Novartis Pharmaceuticals Major Business
Table 60. Novartis Pharmaceuticals Cellular and Gene Therapy Product Product and Services
Table 61. Novartis Pharmaceuticals Cellular and Gene Therapy Product Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 62. Novartis Pharmaceuticals Recent Developments/Updates
Table 63. Castle Creek Biosciences Basic Information, Manufacturing Base and Competitors
Table 64. Castle Creek Biosciences Major Business
Table 65. Castle Creek Biosciences Cellular and Gene Therapy Product Product and Services
Table 66. Castle Creek Biosciences Cellular and Gene Therapy Product Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 67. Castle Creek Biosciences Recent Developments/Updates
Table 68. Spark Therapeutics Basic Information, Manufacturing Base and Competitors
Table 69. Spark Therapeutics Major Business
Table 70. Spark Therapeutics Cellular and Gene Therapy Product Product and Services
Table 71. Spark Therapeutics Cellular and Gene Therapy Product Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 72. Spark Therapeutics Recent Developments/Updates
Table 73. Vericel Basic Information, Manufacturing Base and Competitors
Table 74. Vericel Major Business
Table 75. Vericel Cellular and Gene Therapy Product Product and Services
Table 76. Vericel Cellular and Gene Therapy Product Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 77. Vericel Recent Developments/Updates
Table 78. Dendreon Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 79. Dendreon Pharmaceuticals Major Business
Table 80. Dendreon Pharmaceuticals Cellular and Gene Therapy Product Product and Services
Table 81. Dendreon Pharmaceuticals Cellular and Gene Therapy Product Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 82. Dendreon Pharmaceuticals Recent Developments/Updates
Table 83. Enzyvant Therapeutics GmbH Basic Information, Manufacturing Base and Competitors
Table 84. Enzyvant Therapeutics GmbH Major Business
Table 85. Enzyvant Therapeutics GmbH Cellular and Gene Therapy Product Product and Services
Table 86. Enzyvant Therapeutics GmbH Cellular and Gene Therapy Product Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 87. Enzyvant Therapeutics GmbH Recent Developments/Updates
Table 88. Mallinckrodt Basic Information, Manufacturing Base and Competitors
Table 89. Mallinckrodt Major Business
Table 90. Mallinckrodt Cellular and Gene Therapy Product Product and Services
Table 91. Mallinckrodt Cellular and Gene Therapy Product Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 92. Mallinckrodt Recent Developments/Updates
Table 93. Gilead Sciences Basic Information, Manufacturing Base and Competitors
Table 94. Gilead Sciences Major Business
Table 95. Gilead Sciences Cellular and Gene Therapy Product Product and Services
Table 96. Gilead Sciences Cellular and Gene Therapy Product Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 97. Gilead Sciences Recent Developments/Updates
Table 98. bluebird bio Basic Information, Manufacturing Base and Competitors
Table 99. bluebird bio Major Business
Table 100. bluebird bio Cellular and Gene Therapy Product Product and Services
Table 101. bluebird bio Cellular and Gene Therapy Product Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 102. bluebird bio Recent Developments/Updates
Table 103. Global Cellular and Gene Therapy Product Sales Quantity by Manufacturer (2020-2025) & (K Units)
Table 104. Global Cellular and Gene Therapy Product Revenue by Manufacturer (2020-2025) & (USD Million)
Table 105. Global Cellular and Gene Therapy Product Average Price by Manufacturer (2020-2025) & (US$/Unit)
Table 106. Market Position of Manufacturers in Cellular and Gene Therapy Product, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2024
Table 107. Head Office and Cellular and Gene Therapy Product Production Site of Key Manufacturer
Table 108. Cellular and Gene Therapy Product Market: Company Product Type Footprint
Table 109. Cellular and Gene Therapy Product Market: Company Product Application Footprint
Table 110. Cellular and Gene Therapy Product New Market Entrants and Barriers to Market Entry
Table 111. Cellular and Gene Therapy Product Mergers, Acquisition, Agreements, and Collaborations
Table 112. Global Cellular and Gene Therapy Product Consumption Value by Region (2020-2024-2031) & (USD Million) & CAGR
Table 113. Global Cellular and Gene Therapy Product Sales Quantity by Region (2020-2025) & (K Units)
Table 114. Global Cellular and Gene Therapy Product Sales Quantity by Region (2026-2031) & (K Units)
Table 115. Global Cellular and Gene Therapy Product Consumption Value by Region (2020-2025) & (USD Million)
Table 116. Global Cellular and Gene Therapy Product Consumption Value by Region (2026-2031) & (USD Million)
Table 117. Global Cellular and Gene Therapy Product Average Price by Region (2020-2025) & (US$/Unit)
Table 118. Global Cellular and Gene Therapy Product Average Price by Region (2026-2031) & (US$/Unit)
Table 119. Global Cellular and Gene Therapy Product Sales Quantity by Type (2020-2025) & (K Units)
Table 120. Global Cellular and Gene Therapy Product Sales Quantity by Type (2026-2031) & (K Units)
Table 121. Global Cellular and Gene Therapy Product Consumption Value by Type (2020-2025) & (USD Million)
Table 122. Global Cellular and Gene Therapy Product Consumption Value by Type (2026-2031) & (USD Million)
Table 123. Global Cellular and Gene Therapy Product Average Price by Type (2020-2025) & (US$/Unit)
Table 124. Global Cellular and Gene Therapy Product Average Price by Type (2026-2031) & (US$/Unit)
Table 125. Global Cellular and Gene Therapy Product Sales Quantity by Application (2020-2025) & (K Units)
Table 126. Global Cellular and Gene Therapy Product Sales Quantity by Application (2026-2031) & (K Units)
Table 127. Global Cellular and Gene Therapy Product Consumption Value by Application (2020-2025) & (USD Million)
Table 128. Global Cellular and Gene Therapy Product Consumption Value by Application (2026-2031) & (USD Million)
Table 129. Global Cellular and Gene Therapy Product Average Price by Application (2020-2025) & (US$/Unit)
Table 130. Global Cellular and Gene Therapy Product Average Price by Application (2026-2031) & (US$/Unit)
Table 131. North America Cellular and Gene Therapy Product Sales Quantity by Type (2020-2025) & (K Units)
Table 132. North America Cellular and Gene Therapy Product Sales Quantity by Type (2026-2031) & (K Units)
Table 133. North America Cellular and Gene Therapy Product Sales Quantity by Application (2020-2025) & (K Units)
Table 134. North America Cellular and Gene Therapy Product Sales Quantity by Application (2026-2031) & (K Units)
Table 135. North America Cellular and Gene Therapy Product Sales Quantity by Country (2020-2025) & (K Units)
Table 136. North America Cellular and Gene Therapy Product Sales Quantity by Country (2026-2031) & (K Units)
Table 137. North America Cellular and Gene Therapy Product Consumption Value by Country (2020-2025) & (USD Million)
Table 138. North America Cellular and Gene Therapy Product Consumption Value by Country (2026-2031) & (USD Million)
Table 139. Europe Cellular and Gene Therapy Product Sales Quantity by Type (2020-2025) & (K Units)
Table 140. Europe Cellular and Gene Therapy Product Sales Quantity by Type (2026-2031) & (K Units)
Table 141. Europe Cellular and Gene Therapy Product Sales Quantity by Application (2020-2025) & (K Units)
Table 142. Europe Cellular and Gene Therapy Product Sales Quantity by Application (2026-2031) & (K Units)
Table 143. Europe Cellular and Gene Therapy Product Sales Quantity by Country (2020-2025) & (K Units)
Table 144. Europe Cellular and Gene Therapy Product Sales Quantity by Country (2026-2031) & (K Units)
Table 145. Europe Cellular and Gene Therapy Product Consumption Value by Country (2020-2025) & (USD Million)
Table 146. Europe Cellular and Gene Therapy Product Consumption Value by Country (2026-2031) & (USD Million)
Table 147. Asia-Pacific Cellular and Gene Therapy Product Sales Quantity by Type (2020-2025) & (K Units)
Table 148. Asia-Pacific Cellular and Gene Therapy Product Sales Quantity by Type (2026-2031) & (K Units)
Table 149. Asia-Pacific Cellular and Gene Therapy Product Sales Quantity by Application (2020-2025) & (K Units)
Table 150. Asia-Pacific Cellular and Gene Therapy Product Sales Quantity by Application (2026-2031) & (K Units)
Table 151. Asia-Pacific Cellular and Gene Therapy Product Sales Quantity by Region (2020-2025) & (K Units)
Table 152. Asia-Pacific Cellular and Gene Therapy Product Sales Quantity by Region (2026-2031) & (K Units)
Table 153. Asia-Pacific Cellular and Gene Therapy Product Consumption Value by Region (2020-2025) & (USD Million)
Table 154. Asia-Pacific Cellular and Gene Therapy Product Consumption Value by Region (2026-2031) & (USD Million)
Table 155. South America Cellular and Gene Therapy Product Sales Quantity by Type (2020-2025) & (K Units)
Table 156. South America Cellular and Gene Therapy Product Sales Quantity by Type (2026-2031) & (K Units)
Table 157. South America Cellular and Gene Therapy Product Sales Quantity by Application (2020-2025) & (K Units)
Table 158. South America Cellular and Gene Therapy Product Sales Quantity by Application (2026-2031) & (K Units)
Table 159. South America Cellular and Gene Therapy Product Sales Quantity by Country (2020-2025) & (K Units)
Table 160. South America Cellular and Gene Therapy Product Sales Quantity by Country (2026-2031) & (K Units)
Table 161. South America Cellular and Gene Therapy Product Consumption Value by Country (2020-2025) & (USD Million)
Table 162. South America Cellular and Gene Therapy Product Consumption Value by Country (2026-2031) & (USD Million)
Table 163. Middle East & Africa Cellular and Gene Therapy Product Sales Quantity by Type (2020-2025) & (K Units)
Table 164. Middle East & Africa Cellular and Gene Therapy Product Sales Quantity by Type (2026-2031) & (K Units)
Table 165. Middle East & Africa Cellular and Gene Therapy Product Sales Quantity by Application (2020-2025) & (K Units)
Table 166. Middle East & Africa Cellular and Gene Therapy Product Sales Quantity by Application (2026-2031) & (K Units)
Table 167. Middle East & Africa Cellular and Gene Therapy Product Sales Quantity by Country (2020-2025) & (K Units)
Table 168. Middle East & Africa Cellular and Gene Therapy Product Sales Quantity by Country (2026-2031) & (K Units)
Table 169. Middle East & Africa Cellular and Gene Therapy Product Consumption Value by Country (2020-2025) & (USD Million)
Table 170. Middle East & Africa Cellular and Gene Therapy Product Consumption Value by Country (2026-2031) & (USD Million)
Table 171. Cellular and Gene Therapy Product Raw Material
Table 172. Key Manufacturers of Cellular and Gene Therapy Product Raw Materials
Table 173. Cellular and Gene Therapy Product Typical Distributors
Table 174. Cellular and Gene Therapy Product Typical Customers
Table 1. Global Cellular and Gene Therapy Product Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
Table 2. Global Cellular and Gene Therapy Product Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Table 3. Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table 4. Bristol-Myers Squibb Major Business
Table 5. Bristol-Myers Squibb Cellular and Gene Therapy Product Product and Services
Table 6. Bristol-Myers Squibb Cellular and Gene Therapy Product Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 7. Bristol-Myers Squibb Recent Developments/Updates
Table 8. New York Blood Center Basic Information, Manufacturing Base and Competitors
Table 9. New York Blood Center Major Business
Table 10. New York Blood Center Cellular and Gene Therapy Product Product and Services
Table 11. New York Blood Center Cellular and Gene Therapy Product Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 12. New York Blood Center Recent Developments/Updates
Table 13. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 14. Johnson & Johnson Major Business
Table 15. Johnson & Johnson Cellular and Gene Therapy Product Product and Services
Table 16. Johnson & Johnson Cellular and Gene Therapy Product Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 17. Johnson & Johnson Recent Developments/Updates
Table 18. Cleveland Cord Blood Center Basic Information, Manufacturing Base and Competitors
Table 19. Cleveland Cord Blood Center Major Business
Table 20. Cleveland Cord Blood Center Cellular and Gene Therapy Product Product and Services
Table 21. Cleveland Cord Blood Center Cellular and Gene Therapy Product Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 22. Cleveland Cord Blood Center Recent Developments/Updates
Table 23. Organogenesis Basic Information, Manufacturing Base and Competitors
Table 24. Organogenesis Major Business
Table 25. Organogenesis Cellular and Gene Therapy Product Product and Services
Table 26. Organogenesis Cellular and Gene Therapy Product Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 27. Organogenesis Recent Developments/Updates
Table 28. Duke University School of Medicine Basic Information, Manufacturing Base and Competitors
Table 29. Duke University School of Medicine Major Business
Table 30. Duke University School of Medicine Cellular and Gene Therapy Product Product and Services
Table 31. Duke University School of Medicine Cellular and Gene Therapy Product Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 32. Duke University School of Medicine Recent Developments/Updates
Table 33. Colorado Cord Blood Banking Basic Information, Manufacturing Base and Competitors
Table 34. Colorado Cord Blood Banking Major Business
Table 35. Colorado Cord Blood Banking Cellular and Gene Therapy Product Product and Services
Table 36. Colorado Cord Blood Banking Cellular and Gene Therapy Product Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 37. Colorado Cord Blood Banking Recent Developments/Updates
Table 38. MD Anderson Cancer Center Basic Information, Manufacturing Base and Competitors
Table 39. MD Anderson Cancer Center Major Business
Table 40. MD Anderson Cancer Center Cellular and Gene Therapy Product Product and Services
Table 41. MD Anderson Cancer Center Cellular and Gene Therapy Product Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 42. MD Anderson Cancer Center Recent Developments/Updates
Table 43. LifeSouth Community Blood Centers Basic Information, Manufacturing Base and Competitors
Table 44. LifeSouth Community Blood Centers Major Business
Table 45. LifeSouth Community Blood Centers Cellular and Gene Therapy Product Product and Services
Table 46. LifeSouth Community Blood Centers Cellular and Gene Therapy Product Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 47. LifeSouth Community Blood Centers Recent Developments/Updates
Table 48. Bloodworks Northwest Basic Information, Manufacturing Base and Competitors
Table 49. Bloodworks Northwest Major Business
Table 50. Bloodworks Northwest Cellular and Gene Therapy Product Product and Services
Table 51. Bloodworks Northwest Cellular and Gene Therapy Product Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 52. Bloodworks Northwest Recent Developments/Updates
Table 53. Amgen Basic Information, Manufacturing Base and Competitors
Table 54. Amgen Major Business
Table 55. Amgen Cellular and Gene Therapy Product Product and Services
Table 56. Amgen Cellular and Gene Therapy Product Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 57. Amgen Recent Developments/Updates
Table 58. Novartis Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 59. Novartis Pharmaceuticals Major Business
Table 60. Novartis Pharmaceuticals Cellular and Gene Therapy Product Product and Services
Table 61. Novartis Pharmaceuticals Cellular and Gene Therapy Product Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 62. Novartis Pharmaceuticals Recent Developments/Updates
Table 63. Castle Creek Biosciences Basic Information, Manufacturing Base and Competitors
Table 64. Castle Creek Biosciences Major Business
Table 65. Castle Creek Biosciences Cellular and Gene Therapy Product Product and Services
Table 66. Castle Creek Biosciences Cellular and Gene Therapy Product Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 67. Castle Creek Biosciences Recent Developments/Updates
Table 68. Spark Therapeutics Basic Information, Manufacturing Base and Competitors
Table 69. Spark Therapeutics Major Business
Table 70. Spark Therapeutics Cellular and Gene Therapy Product Product and Services
Table 71. Spark Therapeutics Cellular and Gene Therapy Product Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 72. Spark Therapeutics Recent Developments/Updates
Table 73. Vericel Basic Information, Manufacturing Base and Competitors
Table 74. Vericel Major Business
Table 75. Vericel Cellular and Gene Therapy Product Product and Services
Table 76. Vericel Cellular and Gene Therapy Product Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 77. Vericel Recent Developments/Updates
Table 78. Dendreon Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 79. Dendreon Pharmaceuticals Major Business
Table 80. Dendreon Pharmaceuticals Cellular and Gene Therapy Product Product and Services
Table 81. Dendreon Pharmaceuticals Cellular and Gene Therapy Product Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 82. Dendreon Pharmaceuticals Recent Developments/Updates
Table 83. Enzyvant Therapeutics GmbH Basic Information, Manufacturing Base and Competitors
Table 84. Enzyvant Therapeutics GmbH Major Business
Table 85. Enzyvant Therapeutics GmbH Cellular and Gene Therapy Product Product and Services
Table 86. Enzyvant Therapeutics GmbH Cellular and Gene Therapy Product Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 87. Enzyvant Therapeutics GmbH Recent Developments/Updates
Table 88. Mallinckrodt Basic Information, Manufacturing Base and Competitors
Table 89. Mallinckrodt Major Business
Table 90. Mallinckrodt Cellular and Gene Therapy Product Product and Services
Table 91. Mallinckrodt Cellular and Gene Therapy Product Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 92. Mallinckrodt Recent Developments/Updates
Table 93. Gilead Sciences Basic Information, Manufacturing Base and Competitors
Table 94. Gilead Sciences Major Business
Table 95. Gilead Sciences Cellular and Gene Therapy Product Product and Services
Table 96. Gilead Sciences Cellular and Gene Therapy Product Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 97. Gilead Sciences Recent Developments/Updates
Table 98. bluebird bio Basic Information, Manufacturing Base and Competitors
Table 99. bluebird bio Major Business
Table 100. bluebird bio Cellular and Gene Therapy Product Product and Services
Table 101. bluebird bio Cellular and Gene Therapy Product Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 102. bluebird bio Recent Developments/Updates
Table 103. Global Cellular and Gene Therapy Product Sales Quantity by Manufacturer (2020-2025) & (K Units)
Table 104. Global Cellular and Gene Therapy Product Revenue by Manufacturer (2020-2025) & (USD Million)
Table 105. Global Cellular and Gene Therapy Product Average Price by Manufacturer (2020-2025) & (US$/Unit)
Table 106. Market Position of Manufacturers in Cellular and Gene Therapy Product, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2024
Table 107. Head Office and Cellular and Gene Therapy Product Production Site of Key Manufacturer
Table 108. Cellular and Gene Therapy Product Market: Company Product Type Footprint
Table 109. Cellular and Gene Therapy Product Market: Company Product Application Footprint
Table 110. Cellular and Gene Therapy Product New Market Entrants and Barriers to Market Entry
Table 111. Cellular and Gene Therapy Product Mergers, Acquisition, Agreements, and Collaborations
Table 112. Global Cellular and Gene Therapy Product Consumption Value by Region (2020-2024-2031) & (USD Million) & CAGR
Table 113. Global Cellular and Gene Therapy Product Sales Quantity by Region (2020-2025) & (K Units)
Table 114. Global Cellular and Gene Therapy Product Sales Quantity by Region (2026-2031) & (K Units)
Table 115. Global Cellular and Gene Therapy Product Consumption Value by Region (2020-2025) & (USD Million)
Table 116. Global Cellular and Gene Therapy Product Consumption Value by Region (2026-2031) & (USD Million)
Table 117. Global Cellular and Gene Therapy Product Average Price by Region (2020-2025) & (US$/Unit)
Table 118. Global Cellular and Gene Therapy Product Average Price by Region (2026-2031) & (US$/Unit)
Table 119. Global Cellular and Gene Therapy Product Sales Quantity by Type (2020-2025) & (K Units)
Table 120. Global Cellular and Gene Therapy Product Sales Quantity by Type (2026-2031) & (K Units)
Table 121. Global Cellular and Gene Therapy Product Consumption Value by Type (2020-2025) & (USD Million)
Table 122. Global Cellular and Gene Therapy Product Consumption Value by Type (2026-2031) & (USD Million)
Table 123. Global Cellular and Gene Therapy Product Average Price by Type (2020-2025) & (US$/Unit)
Table 124. Global Cellular and Gene Therapy Product Average Price by Type (2026-2031) & (US$/Unit)
Table 125. Global Cellular and Gene Therapy Product Sales Quantity by Application (2020-2025) & (K Units)
Table 126. Global Cellular and Gene Therapy Product Sales Quantity by Application (2026-2031) & (K Units)
Table 127. Global Cellular and Gene Therapy Product Consumption Value by Application (2020-2025) & (USD Million)
Table 128. Global Cellular and Gene Therapy Product Consumption Value by Application (2026-2031) & (USD Million)
Table 129. Global Cellular and Gene Therapy Product Average Price by Application (2020-2025) & (US$/Unit)
Table 130. Global Cellular and Gene Therapy Product Average Price by Application (2026-2031) & (US$/Unit)
Table 131. North America Cellular and Gene Therapy Product Sales Quantity by Type (2020-2025) & (K Units)
Table 132. North America Cellular and Gene Therapy Product Sales Quantity by Type (2026-2031) & (K Units)
Table 133. North America Cellular and Gene Therapy Product Sales Quantity by Application (2020-2025) & (K Units)
Table 134. North America Cellular and Gene Therapy Product Sales Quantity by Application (2026-2031) & (K Units)
Table 135. North America Cellular and Gene Therapy Product Sales Quantity by Country (2020-2025) & (K Units)
Table 136. North America Cellular and Gene Therapy Product Sales Quantity by Country (2026-2031) & (K Units)
Table 137. North America Cellular and Gene Therapy Product Consumption Value by Country (2020-2025) & (USD Million)
Table 138. North America Cellular and Gene Therapy Product Consumption Value by Country (2026-2031) & (USD Million)
Table 139. Europe Cellular and Gene Therapy Product Sales Quantity by Type (2020-2025) & (K Units)
Table 140. Europe Cellular and Gene Therapy Product Sales Quantity by Type (2026-2031) & (K Units)
Table 141. Europe Cellular and Gene Therapy Product Sales Quantity by Application (2020-2025) & (K Units)
Table 142. Europe Cellular and Gene Therapy Product Sales Quantity by Application (2026-2031) & (K Units)
Table 143. Europe Cellular and Gene Therapy Product Sales Quantity by Country (2020-2025) & (K Units)
Table 144. Europe Cellular and Gene Therapy Product Sales Quantity by Country (2026-2031) & (K Units)
Table 145. Europe Cellular and Gene Therapy Product Consumption Value by Country (2020-2025) & (USD Million)
Table 146. Europe Cellular and Gene Therapy Product Consumption Value by Country (2026-2031) & (USD Million)
Table 147. Asia-Pacific Cellular and Gene Therapy Product Sales Quantity by Type (2020-2025) & (K Units)
Table 148. Asia-Pacific Cellular and Gene Therapy Product Sales Quantity by Type (2026-2031) & (K Units)
Table 149. Asia-Pacific Cellular and Gene Therapy Product Sales Quantity by Application (2020-2025) & (K Units)
Table 150. Asia-Pacific Cellular and Gene Therapy Product Sales Quantity by Application (2026-2031) & (K Units)
Table 151. Asia-Pacific Cellular and Gene Therapy Product Sales Quantity by Region (2020-2025) & (K Units)
Table 152. Asia-Pacific Cellular and Gene Therapy Product Sales Quantity by Region (2026-2031) & (K Units)
Table 153. Asia-Pacific Cellular and Gene Therapy Product Consumption Value by Region (2020-2025) & (USD Million)
Table 154. Asia-Pacific Cellular and Gene Therapy Product Consumption Value by Region (2026-2031) & (USD Million)
Table 155. South America Cellular and Gene Therapy Product Sales Quantity by Type (2020-2025) & (K Units)
Table 156. South America Cellular and Gene Therapy Product Sales Quantity by Type (2026-2031) & (K Units)
Table 157. South America Cellular and Gene Therapy Product Sales Quantity by Application (2020-2025) & (K Units)
Table 158. South America Cellular and Gene Therapy Product Sales Quantity by Application (2026-2031) & (K Units)
Table 159. South America Cellular and Gene Therapy Product Sales Quantity by Country (2020-2025) & (K Units)
Table 160. South America Cellular and Gene Therapy Product Sales Quantity by Country (2026-2031) & (K Units)
Table 161. South America Cellular and Gene Therapy Product Consumption Value by Country (2020-2025) & (USD Million)
Table 162. South America Cellular and Gene Therapy Product Consumption Value by Country (2026-2031) & (USD Million)
Table 163. Middle East & Africa Cellular and Gene Therapy Product Sales Quantity by Type (2020-2025) & (K Units)
Table 164. Middle East & Africa Cellular and Gene Therapy Product Sales Quantity by Type (2026-2031) & (K Units)
Table 165. Middle East & Africa Cellular and Gene Therapy Product Sales Quantity by Application (2020-2025) & (K Units)
Table 166. Middle East & Africa Cellular and Gene Therapy Product Sales Quantity by Application (2026-2031) & (K Units)
Table 167. Middle East & Africa Cellular and Gene Therapy Product Sales Quantity by Country (2020-2025) & (K Units)
Table 168. Middle East & Africa Cellular and Gene Therapy Product Sales Quantity by Country (2026-2031) & (K Units)
Table 169. Middle East & Africa Cellular and Gene Therapy Product Consumption Value by Country (2020-2025) & (USD Million)
Table 170. Middle East & Africa Cellular and Gene Therapy Product Consumption Value by Country (2026-2031) & (USD Million)
Table 171. Cellular and Gene Therapy Product Raw Material
Table 172. Key Manufacturers of Cellular and Gene Therapy Product Raw Materials
Table 173. Cellular and Gene Therapy Product Typical Distributors
Table 174. Cellular and Gene Therapy Product Typical Customers
LIST OF FIGURES
Figure 1. Cellular and Gene Therapy Product Picture
Figure 2. Global Cellular and Gene Therapy Product Revenue by Type, (USD Million), 2020 & 2024 & 2031
Figure 3. Global Cellular and Gene Therapy Product Revenue Market Share by Type in 2024
Figure 4. Cellular Immunotherapies Examples
Figure 5. Cancer Vaccines Examples
Figure 6. Autologous and Allogeneic Cells Examples
Figure 7. Global Cellular and Gene Therapy Product Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Figure 8. Global Cellular and Gene Therapy Product Revenue Market Share by Application in 2024
Figure 9. Blood Cancer Examples
Figure 10. Prostate Cancer Examples
Figure 11. Skin Cancer Examples
Figure 12. Other Examples
Figure 13. Global Cellular and Gene Therapy Product Consumption Value, (USD Million): 2020 & 2024 & 2031
Figure 14. Global Cellular and Gene Therapy Product Consumption Value and Forecast (2020-2031) & (USD Million)
Figure 15. Global Cellular and Gene Therapy Product Sales Quantity (2020-2031) & (K Units)
Figure 16. Global Cellular and Gene Therapy Product Price (2020-2031) & (US$/Unit)
Figure 17. Global Cellular and Gene Therapy Product Sales Quantity Market Share by Manufacturer in 2024
Figure 18. Global Cellular and Gene Therapy Product Revenue Market Share by Manufacturer in 2024
Figure 19. Producer Shipments of Cellular and Gene Therapy Product by Manufacturer Sales ($MM) and Market Share (%): 2024
Figure 20. Top 3 Cellular and Gene Therapy Product Manufacturer (Revenue) Market Share in 2024
Figure 21. Top 6 Cellular and Gene Therapy Product Manufacturer (Revenue) Market Share in 2024
Figure 22. Global Cellular and Gene Therapy Product Sales Quantity Market Share by Region (2020-2031)
Figure 23. Global Cellular and Gene Therapy Product Consumption Value Market Share by Region (2020-2031)
Figure 24. North America Cellular and Gene Therapy Product Consumption Value (2020-2031) & (USD Million)
Figure 25. Europe Cellular and Gene Therapy Product Consumption Value (2020-2031) & (USD Million)
Figure 26. Asia-Pacific Cellular and Gene Therapy Product Consumption Value (2020-2031) & (USD Million)
Figure 27. South America Cellular and Gene Therapy Product Consumption Value (2020-2031) & (USD Million)
Figure 28. Middle East & Africa Cellular and Gene Therapy Product Consumption Value (2020-2031) & (USD Million)
Figure 29. Global Cellular and Gene Therapy Product Sales Quantity Market Share by Type (2020-2031)
Figure 30. Global Cellular and Gene Therapy Product Consumption Value Market Share by Type (2020-2031)
Figure 31. Global Cellular and Gene Therapy Product Average Price by Type (2020-2031) & (US$/Unit)
Figure 32. Global Cellular and Gene Therapy Product Sales Quantity Market Share by Application (2020-2031)
Figure 33. Global Cellular and Gene Therapy Product Revenue Market Share by Application (2020-2031)
Figure 34. Global Cellular and Gene Therapy Product Average Price by Application (2020-2031) & (US$/Unit)
Figure 35. North America Cellular and Gene Therapy Product Sales Quantity Market Share by Type (2020-2031)
Figure 36. North America Cellular and Gene Therapy Product Sales Quantity Market Share by Application (2020-2031)
Figure 37. North America Cellular and Gene Therapy Product Sales Quantity Market Share by Country (2020-2031)
Figure 38. North America Cellular and Gene Therapy Product Consumption Value Market Share by Country (2020-2031)
Figure 39. United States Cellular and Gene Therapy Product Consumption Value (2020-2031) & (USD Million)
Figure 40. Canada Cellular and Gene Therapy Product Consumption Value (2020-2031) & (USD Million)
Figure 41. Mexico Cellular and Gene Therapy Product Consumption Value (2020-2031) & (USD Million)
Figure 42. Europe Cellular and Gene Therapy Product Sales Quantity Market Share by Type (2020-2031)
Figure 43. Europe Cellular and Gene Therapy Product Sales Quantity Market Share by Application (2020-2031)
Figure 44. Europe Cellular and Gene Therapy Product Sales Quantity Market Share by Country (2020-2031)
Figure 45. Europe Cellular and Gene Therapy Product Consumption Value Market Share by Country (2020-2031)
Figure 46. Germany Cellular and Gene Therapy Product Consumption Value (2020-2031) & (USD Million)
Figure 47. France Cellular and Gene Therapy Product Consumption Value (2020-2031) & (USD Million)
Figure 48. United Kingdom Cellular and Gene Therapy Product Consumption Value (2020-2031) & (USD Million)
Figure 49. Russia Cellular and Gene Therapy Product Consumption Value (2020-2031) & (USD Million)
Figure 50. Italy Cellular and Gene Therapy Product Consumption Value (2020-2031) & (USD Million)
Figure 51. Asia-Pacific Cellular and Gene Therapy Product Sales Quantity Market Share by Type (2020-2031)
Figure 52. Asia-Pacific Cellular and Gene Therapy Product Sales Quantity Market Share by Application (2020-2031)
Figure 53. Asia-Pacific Cellular and Gene Therapy Product Sales Quantity Market Share by Region (2020-2031)
Figure 54. Asia-Pacific Cellular and Gene Therapy Product Consumption Value Market Share by Region (2020-2031)
Figure 55. China Cellular and Gene Therapy Product Consumption Value (2020-2031) & (USD Million)
Figure 56. Japan Cellular and Gene Therapy Product Consumption Value (2020-2031) & (USD Million)
Figure 57. South Korea Cellular and Gene Therapy Product Consumption Value (2020-2031) & (USD Million)
Figure 58. India Cellular and Gene Therapy Product Consumption Value (2020-2031) & (USD Million)
Figure 59. Southeast Asia Cellular and Gene Therapy Product Consumption Value (2020-2031) & (USD Million)
Figure 60. Australia Cellular and Gene Therapy Product Consumption Value (2020-2031) & (USD Million)
Figure 61. South America Cellular and Gene Therapy Product Sales Quantity Market Share by Type (2020-2031)
Figure 62. South America Cellular and Gene Therapy Product Sales Quantity Market Share by Application (2020-2031)
Figure 63. South America Cellular and Gene Therapy Product Sales Quantity Market Share by Country (2020-2031)
Figure 64. South America Cellular and Gene Therapy Product Consumption Value Market Share by Country (2020-2031)
Figure 65. Brazil Cellular and Gene Therapy Product Consumption Value (2020-2031) & (USD Million)
Figure 66. Argentina Cellular and Gene Therapy Product Consumption Value (2020-2031) & (USD Million)
Figure 67. Middle East & Africa Cellular and Gene Therapy Product Sales Quantity Market Share by Type (2020-2031)
Figure 68. Middle East & Africa Cellular and Gene Therapy Product Sales Quantity Market Share by Application (2020-2031)
Figure 69. Middle East & Africa Cellular and Gene Therapy Product Sales Quantity Market Share by Country (2020-2031)
Figure 70. Middle East & Africa Cellular and Gene Therapy Product Consumption Value Market Share by Country (2020-2031)
Figure 71. Turkey Cellular and Gene Therapy Product Consumption Value (2020-2031) & (USD Million)
Figure 72. Egypt Cellular and Gene Therapy Product Consumption Value (2020-2031) & (USD Million)
Figure 73. Saudi Arabia Cellular and Gene Therapy Product Consumption Value (2020-2031) & (USD Million)
Figure 74. South Africa Cellular and Gene Therapy Product Consumption Value (2020-2031) & (USD Million)
Figure 75. Cellular and Gene Therapy Product Market Drivers
Figure 76. Cellular and Gene Therapy Product Market Restraints
Figure 77. Cellular and Gene Therapy Product Market Trends
Figure 78. Porters Five Forces Analysis
Figure 79. Manufacturing Cost Structure Analysis of Cellular and Gene Therapy Product in 2024
Figure 80. Manufacturing Process Analysis of Cellular and Gene Therapy Product
Figure 81. Cellular and Gene Therapy Product Industrial Chain
Figure 82. Sales Channel: Direct to End-User vs Distributors
Figure 83. Direct Channel Pros & Cons
Figure 84. Indirect Channel Pros & Cons
Figure 85. Methodology
Figure 86. Research Process and Data Source
Figure 1. Cellular and Gene Therapy Product Picture
Figure 2. Global Cellular and Gene Therapy Product Revenue by Type, (USD Million), 2020 & 2024 & 2031
Figure 3. Global Cellular and Gene Therapy Product Revenue Market Share by Type in 2024
Figure 4. Cellular Immunotherapies Examples
Figure 5. Cancer Vaccines Examples
Figure 6. Autologous and Allogeneic Cells Examples
Figure 7. Global Cellular and Gene Therapy Product Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Figure 8. Global Cellular and Gene Therapy Product Revenue Market Share by Application in 2024
Figure 9. Blood Cancer Examples
Figure 10. Prostate Cancer Examples
Figure 11. Skin Cancer Examples
Figure 12. Other Examples
Figure 13. Global Cellular and Gene Therapy Product Consumption Value, (USD Million): 2020 & 2024 & 2031
Figure 14. Global Cellular and Gene Therapy Product Consumption Value and Forecast (2020-2031) & (USD Million)
Figure 15. Global Cellular and Gene Therapy Product Sales Quantity (2020-2031) & (K Units)
Figure 16. Global Cellular and Gene Therapy Product Price (2020-2031) & (US$/Unit)
Figure 17. Global Cellular and Gene Therapy Product Sales Quantity Market Share by Manufacturer in 2024
Figure 18. Global Cellular and Gene Therapy Product Revenue Market Share by Manufacturer in 2024
Figure 19. Producer Shipments of Cellular and Gene Therapy Product by Manufacturer Sales ($MM) and Market Share (%): 2024
Figure 20. Top 3 Cellular and Gene Therapy Product Manufacturer (Revenue) Market Share in 2024
Figure 21. Top 6 Cellular and Gene Therapy Product Manufacturer (Revenue) Market Share in 2024
Figure 22. Global Cellular and Gene Therapy Product Sales Quantity Market Share by Region (2020-2031)
Figure 23. Global Cellular and Gene Therapy Product Consumption Value Market Share by Region (2020-2031)
Figure 24. North America Cellular and Gene Therapy Product Consumption Value (2020-2031) & (USD Million)
Figure 25. Europe Cellular and Gene Therapy Product Consumption Value (2020-2031) & (USD Million)
Figure 26. Asia-Pacific Cellular and Gene Therapy Product Consumption Value (2020-2031) & (USD Million)
Figure 27. South America Cellular and Gene Therapy Product Consumption Value (2020-2031) & (USD Million)
Figure 28. Middle East & Africa Cellular and Gene Therapy Product Consumption Value (2020-2031) & (USD Million)
Figure 29. Global Cellular and Gene Therapy Product Sales Quantity Market Share by Type (2020-2031)
Figure 30. Global Cellular and Gene Therapy Product Consumption Value Market Share by Type (2020-2031)
Figure 31. Global Cellular and Gene Therapy Product Average Price by Type (2020-2031) & (US$/Unit)
Figure 32. Global Cellular and Gene Therapy Product Sales Quantity Market Share by Application (2020-2031)
Figure 33. Global Cellular and Gene Therapy Product Revenue Market Share by Application (2020-2031)
Figure 34. Global Cellular and Gene Therapy Product Average Price by Application (2020-2031) & (US$/Unit)
Figure 35. North America Cellular and Gene Therapy Product Sales Quantity Market Share by Type (2020-2031)
Figure 36. North America Cellular and Gene Therapy Product Sales Quantity Market Share by Application (2020-2031)
Figure 37. North America Cellular and Gene Therapy Product Sales Quantity Market Share by Country (2020-2031)
Figure 38. North America Cellular and Gene Therapy Product Consumption Value Market Share by Country (2020-2031)
Figure 39. United States Cellular and Gene Therapy Product Consumption Value (2020-2031) & (USD Million)
Figure 40. Canada Cellular and Gene Therapy Product Consumption Value (2020-2031) & (USD Million)
Figure 41. Mexico Cellular and Gene Therapy Product Consumption Value (2020-2031) & (USD Million)
Figure 42. Europe Cellular and Gene Therapy Product Sales Quantity Market Share by Type (2020-2031)
Figure 43. Europe Cellular and Gene Therapy Product Sales Quantity Market Share by Application (2020-2031)
Figure 44. Europe Cellular and Gene Therapy Product Sales Quantity Market Share by Country (2020-2031)
Figure 45. Europe Cellular and Gene Therapy Product Consumption Value Market Share by Country (2020-2031)
Figure 46. Germany Cellular and Gene Therapy Product Consumption Value (2020-2031) & (USD Million)
Figure 47. France Cellular and Gene Therapy Product Consumption Value (2020-2031) & (USD Million)
Figure 48. United Kingdom Cellular and Gene Therapy Product Consumption Value (2020-2031) & (USD Million)
Figure 49. Russia Cellular and Gene Therapy Product Consumption Value (2020-2031) & (USD Million)
Figure 50. Italy Cellular and Gene Therapy Product Consumption Value (2020-2031) & (USD Million)
Figure 51. Asia-Pacific Cellular and Gene Therapy Product Sales Quantity Market Share by Type (2020-2031)
Figure 52. Asia-Pacific Cellular and Gene Therapy Product Sales Quantity Market Share by Application (2020-2031)
Figure 53. Asia-Pacific Cellular and Gene Therapy Product Sales Quantity Market Share by Region (2020-2031)
Figure 54. Asia-Pacific Cellular and Gene Therapy Product Consumption Value Market Share by Region (2020-2031)
Figure 55. China Cellular and Gene Therapy Product Consumption Value (2020-2031) & (USD Million)
Figure 56. Japan Cellular and Gene Therapy Product Consumption Value (2020-2031) & (USD Million)
Figure 57. South Korea Cellular and Gene Therapy Product Consumption Value (2020-2031) & (USD Million)
Figure 58. India Cellular and Gene Therapy Product Consumption Value (2020-2031) & (USD Million)
Figure 59. Southeast Asia Cellular and Gene Therapy Product Consumption Value (2020-2031) & (USD Million)
Figure 60. Australia Cellular and Gene Therapy Product Consumption Value (2020-2031) & (USD Million)
Figure 61. South America Cellular and Gene Therapy Product Sales Quantity Market Share by Type (2020-2031)
Figure 62. South America Cellular and Gene Therapy Product Sales Quantity Market Share by Application (2020-2031)
Figure 63. South America Cellular and Gene Therapy Product Sales Quantity Market Share by Country (2020-2031)
Figure 64. South America Cellular and Gene Therapy Product Consumption Value Market Share by Country (2020-2031)
Figure 65. Brazil Cellular and Gene Therapy Product Consumption Value (2020-2031) & (USD Million)
Figure 66. Argentina Cellular and Gene Therapy Product Consumption Value (2020-2031) & (USD Million)
Figure 67. Middle East & Africa Cellular and Gene Therapy Product Sales Quantity Market Share by Type (2020-2031)
Figure 68. Middle East & Africa Cellular and Gene Therapy Product Sales Quantity Market Share by Application (2020-2031)
Figure 69. Middle East & Africa Cellular and Gene Therapy Product Sales Quantity Market Share by Country (2020-2031)
Figure 70. Middle East & Africa Cellular and Gene Therapy Product Consumption Value Market Share by Country (2020-2031)
Figure 71. Turkey Cellular and Gene Therapy Product Consumption Value (2020-2031) & (USD Million)
Figure 72. Egypt Cellular and Gene Therapy Product Consumption Value (2020-2031) & (USD Million)
Figure 73. Saudi Arabia Cellular and Gene Therapy Product Consumption Value (2020-2031) & (USD Million)
Figure 74. South Africa Cellular and Gene Therapy Product Consumption Value (2020-2031) & (USD Million)
Figure 75. Cellular and Gene Therapy Product Market Drivers
Figure 76. Cellular and Gene Therapy Product Market Restraints
Figure 77. Cellular and Gene Therapy Product Market Trends
Figure 78. Porters Five Forces Analysis
Figure 79. Manufacturing Cost Structure Analysis of Cellular and Gene Therapy Product in 2024
Figure 80. Manufacturing Process Analysis of Cellular and Gene Therapy Product
Figure 81. Cellular and Gene Therapy Product Industrial Chain
Figure 82. Sales Channel: Direct to End-User vs Distributors
Figure 83. Direct Channel Pros & Cons
Figure 84. Indirect Channel Pros & Cons
Figure 85. Methodology
Figure 86. Research Process and Data Source
